Navigation Links
Europe Non-Small Cell Lung Cancer Treatments Market to Cross US$ 3 Billion by 2019 Says Pharmaion

BURNABY, British Columbia, January 18, 2016 /PRNewswire/ --

Growing technological advancements and anticipated launch of various pipeline drugs to drive non-small cell lung cancer treatments market in Europe

According to recently published Pharmaion report, "Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020", the non-small cell lung cancer (NSCLC) treatments market in Europe is anticipated to cross US$ 3 billion by 2019. Growth in the market is anticipated on account of increasing NSCLC prevalence rate, continuous exposure to radiation and carcinogens and growing patient awareness. Moreover, late appearance of disease symptoms leads to delay in diagnosis and advancement in the cancer stage, which results in increasing the cost of the treatment, and thereby generate higher revenues for Europe NSCLC treatments market.

In Europe, majority of the lung cancer patients were found to be suffering from NSCLC in 2014, and the trend is anticipated to continue through 2020. With increasing prevalence of NSCLC among European citizens, the demand for the treatments and therapies is forecast to grow at a robust pace in the next five years. Moreover, anticipated launch of multiple drugs across different classes of therapies is further anticipated to aid the non-small cell lung cancer treatments market in Europe during 2015 - 2020. However, patent expiration of drug and increasing availability of generic medicine are posing a challenge to the NSCLC treatments market in Europe.

On the basis of therapy offered, the market has been segmented into four broad categories, namely, chemotherapy, radiotherapy, surgery and target therapy. Among these categories, chemotherapy segment dominated the Europe non-small cell lung cancer treatments market in 2014. With various number of new drug entrants, coupled with numerous clinical trials in pipeline, the segment is anticipated to continue its dominance in the Europe NSCLC treatments market through 2020. Country-wise, the largest share in Europe's NSCLC treatments market was captured by Germany, followed by France, Italy, Spain and the UK.

"Europe non-small cell lung cancer treatments market will continue to exhibit promising growth over the next five years. Innovation and new product launches by the existing as well as the new market players is the major factor anticipated to drive non-small cell lung cancer treatments market during the forecast period. Moreover, growing adoption of Video Assisted Thoracic Surgery, Photodynamic Therapy and Laser Therapy, coupled with increasing applications of monoclonal antibodies and immunotherapy are among the major factors driving Europe non-small cell lung cancer treatments market." said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical and healthcare consulting firm.

"Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020" has analyzed the potential of non-small cell lung cancer treatments market in Europe and provides statistics and information on market sizes, shares and trends. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes the emerging trends along with essential drivers and key challenges faced by the non-small cell lung cancer treatments market in Europe.

About Pharmaion 

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion's clients lead rather than follow market trends. Pharmaion has developed a proprietary database which focuses on identifying the unexplored opportunities in Healthcare and Pharmaceutical industry.

Media Contact
Karan Chechi
Research Director
Contact Phone: +1-646-862-0089

SOURCE Pharmaion
Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
2. European Bioplastics publie des données sur lutilisation des terres pour les bioplastiques
3. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
4. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
5. GenoVive, a pioneer in DNA-based weight management solutions, today announced the companys first European partnership as of May 1, 2013 with DNADIETA based in Poland.
6. European Inventor Award 2013 Goes to Outstanding Inventors From Austria, France, Sweden, Switzerland, Spain and the US
7. Giornata mondiale senza tabacco 2013: una pietra miliare della campagna "Gli ex-fumatori sono irresistibili" della Commissione europea
8. Werelddag tegen tabak 2013: fantastische mijlpaal in campagne van Europese Commissie Ex-rokers zijn niet te stoppen
9. GSMA: The Adoption Of mHealth Could Reduce Total Annual European Healthcare Spend By Almost Euro 100 Billion In 2017
10. BioNano Genomics Launches Irys In Europe At ESHG 2013
11. Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
Post Your Comments:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):